3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
35
Thoracic
1
Lymphoid
1
Genitourinary
1
Conditions
Lymphoma
549
Precursor Cell Lymphoblastic Leukemia-Lymphoma
511
Lymphoma, Non-Hodgkin
437
Lymphoma, Follicular
405
Lymphoma, Large B-Cell, Diffuse
392
Leukemia, Lymphocytic, Chronic, B-Cell
392
Lymphoma, B-Cell
248
Lymphoma, Mantle-Cell
224
Hodgkin Disease
209
Recurrence
205
Leukemia, Myeloid, Acute
199
Leukemia
196
Multiple Myeloma
185
Burkitt Lymphoma
185
Lymphoma, B-Cell, Marginal Zone
170
Neoplasms
153
Myelodysplastic Syndromes
134
Hematologic Neoplasms
115
Waldenstrom Macroglobulinemia
103
Lymphoma, T-Cell, Peripheral
86
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
83
Lymphoma, T-Cell
82
Lymphoma, T-Cell, Cutaneous
67
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
63
Mycosis Fungoides
57
Leukemia, Biphenotypic, Acute
55
Breast Neoplasms
55
Leukemia, B-Cell
52
Myeloproliferative Disorders
50
Lymphoproliferative Disorders
47
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Liver Cirrhosis
×
Lymphoid
×
1 year
×
Clear all
NCT06812780
2025-09-24
CAMPOLINA
AstraZeneca
Phase 1
Completed
35 enrolled